- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/64 - Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
Patent holdings for IPC class C07D 277/64
Total number of patents in this class: 472
10-year publication summary
|
43
|
42
|
23
|
30
|
23
|
32
|
27
|
38
|
16
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4795 |
15 |
| EyePoint Pharmaceuticals, Inc. | 99 |
12 |
| Antabio SAS | 23 |
9 |
| Rutgers, The State University of New Jersey | 1956 |
9 |
| The Regents of the University of Michigan | 4851 |
8 |
| FUJIFILM Corporation | 30063 |
7 |
| Avexxin AS | 44 |
7 |
| CHDI Foundation, Inc. | 105 |
7 |
| Escient Pharmaceuticals, Inc. | 44 |
7 |
| Janssen Pharmaceutica N.V. | 3304 |
6 |
| The General Hospital Corporation | 4796 |
6 |
| Lighthouse Pharmaceuticals, Inc. | 11 |
6 |
| Genentech, Inc. | 4045 |
5 |
| Takeda Pharmaceutical Company Limited | 2713 |
5 |
| Genzyme Corporation | 1320 |
5 |
| Gilead Sciences, Inc. | 2140 |
5 |
| King Faisal University | 921 |
5 |
| National Institutes for Quantum and Radiological Science and Technology | 103 |
5 |
| Sun Pharma Advanced Research Company Ltd. | 194 |
5 |
| Hoffmann-La Roche Inc. | 3620 |
4 |
| Other owners | 334 |